CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2017; 21(03): 308-312
DOI: 10.1055/s-0037-1601400
Systematic Review
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Adenomatous Tumors of the Middle Ear: A Literature Review

Flavia Amarante Cardoso
1   Department of Otorhinolaryngology, Hospital Felicio Rocho, Belo Horizonte, Brazil
,
Eduardo Machado Rossi Monteiro
1   Department of Otorhinolaryngology, Hospital Felicio Rocho, Belo Horizonte, Brazil
,
Livia Bernardi Lopes
1   Department of Otorhinolaryngology, Hospital Felicio Rocho, Belo Horizonte, Brazil
,
Marianna Novaes da Costa Avila
1   Department of Otorhinolaryngology, Hospital Felicio Rocho, Belo Horizonte, Brazil
,
Bernardo Oliveira Scarioli
1   Department of Otorhinolaryngology, Hospital Felicio Rocho, Belo Horizonte, Brazil
› Author Affiliations
Further Information

Publication History

03 October 2016

22 January 2017

Publication Date:
28 April 2017 (online)

Abstract

Introduction Neuroendocrine adenomas of the middle ear (NAME) are uncommon causes of middle ear masses. Mostly limited to case reports and small series, the literature is poor in providing an overall assessment of these tumors.

Objective To review the current literature about all aspects of the disease, including its etiology, clinical manifestations, diagnosis, and treatment.

Data Synthesis The pathogenesis of adenomatous tumors of the middle ear is not clear yet. One potential explanation is that an undifferentiated pluripotent endodermal stem cell may still be present in the middle ear mucosal surface, and may be the origin of the tumors. It typically appears as a nonspecific retrotympanic mass. The average age of onset for the disease is the fifth decade, and the most common clinical symptom is conductive hearing loss. Malign behavior is rare. There are numerous differential diagnoses of NAME. The final diagnosis depends on microscopic findings. The preoperative evaluation should include the use of computed tomography and magnetic resonance imaging. The adjunctive therapy of middle ear adenomatous tumors with radiotherapy, chemotherapy or somatostatin analogs is generally not recommended.

Conclusion There is still much debate on pathogenesis and classification of NAME. Saliba's classification is currently the most complete and preferable one. Aggressive surgical procedure with ossicular chain excision is the gold standard treatment. Follow-up with physical and radiological exams is mandatory, particularly if the first procedure was conservative, without the removal of the encased ossicles.

 
  • References

  • 1 Hyams VJ, Michaels L. Benign adenomatous neoplasm (adenoma) of the middle ear. Clin Otolaryngol Allied Sci 1976; 1 (01) 17-26
  • 2 Murphy GF, Pilch BZ, Dickersin GR, Goodman ML, Nadol Jr JB. Carcinoid tumor of the middle ear. Am J Clin Pathol 1980; 73 (06) 816-823
  • 3 Almuhanna K. Neuroendocrine adenoma of the middle ear with the history of otitis media and carcinoma of the cheek: a case report. BMC Res Notes 2014; 7: 532
  • 4 Torske KR, Thompson LDR. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 2002; 15 (05) 543-555
  • 5 Lott Limbach AA, Hoschar AP, Thompson LD, Stelow EB, Chute DJ. Middle ear adenomas stain for two cell populations and lack myoepithelial cell differentiation. Head Neck Pathol 2012; 6 (03) 345-353
  • 6 Pelosi S, Koss S. Adenomatous tumors of the middle ear. Otolaryngol Clin North Am 2015; 48 (02) 305-315
  • 7 Saliba I, Evrard AS. Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J 2009; 2 (6508): 6508
  • 8 Ayache S, Braccini F, Fernandes M, Homassin JM. Adenoma of the middle ear: a rare and misleading lesion. Otol Neurotol 2002; 23 (06) 988-991
  • 9 Ramsey MJ, Nadol Jr JB, Pilch BZ, McKenna MJ. Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope 2005; 115 (09) 1660-1666
  • 10 Mooney EE, Dodd LG, Oury TD, Burchette JL, Layfield LJ, Scher RL. Middle ear carcinoid: an indolent tumor with metastatic potential. Head Neck 1999; 21 (01) 72-77
  • 11 Tomazic PV, Beham A, Lackner A, Ropposch T, Stockreiter U, Walch C. Neuroendocrine adenoma of the middle ear (NAME) mimicking as chronic otitis media with an episode of facial nerve palsy. B-ENT 2011; 7 (02) 121-125
  • 12 Nikanne E, Kantola O, Parviainen T. [Carcinoid tumor of middle ear]. Duodecim 2003; 119 (11) 1081-1084
  • 13 Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol 2006; 42 (08) 770-788
  • 14 Cruz Toro P, Domenech I, Clemente I. , et al. Temporal bone histopathology case of the month neuroendocrine adenoma of the middle ear. Otol Neurotol 2011; 33: 7-8
  • 15 Isenring D, Pezier TF, Vrugt B, Huber AM. Middle ear adenoma: case report and discussion. Case Rep Otolaryngol 2014; 2014 (342125): 342125
  • 16 Godelieve WJA, Engen-van Grunsven IACH, van der Schans EJ, Kunst HPM. , et al. Temporal Bone Histopathology Case of the Month: A White Mass Behind the Tympanic Membrane: Adenoma of the Middle Ear with Neuroendocrine Differentiation. Otol Neurotol 2011; 32: 38-39
  • 17 Gut SM, Wagner B, Kessler M, Linder T. [Neuroendocrine adenoma of the middle ear]. HNO 2014; 62 (03) 180 , 182–185